Showing
1 - 4
results of
4
for search '
Shafrin J
'
Skip to content
Home
High Impact Articles
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
Jawi Collection
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Shafrin J
Showing
1 - 4
results of
4
for search '
Shafrin J
'
, query time: 0.04s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness
by
Shafrin
J
,
Bognar K
,
Everson K
,
Brauer M
,
Lakdawalla DN
,
Forma FM
Published 2018-10-01
Get full text
Article
2
The effect of medication nonadherence on progression-free survival among patients with renal cell carcinoma
by
Shafrin
J
,
Sullivan J
,
Chou JW
,
Neely MN
,
Doan JF
,
Maclean JR
Published 2017-11-01
Get full text
Article
3
For which diseases do broader value elements matter most? An evaluation across 20 ICER evidence reports
by
Bhor, M.
,
Birch, K.
,
Dennen, S.
,
Kanter, J.
,
Neumann, P.
,
Pednekar, P.
,
Shafrin
,
J
.
Published 2021
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
4
Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of provide...
by
Shafrin
J
,
May SG
,
Shrestha A
,
Ruetsch C
,
Gerlanc N
,
Forma F
,
Hatch A
,
Lakdawalla DN
,
Lindenmayer JP
Published 2017-06-01
Get full text
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Article
Cost-Benefit Analysis
Disease
Drug Therapy
Health Care Costs
Humans
Medical Oncology
Quality-Adjusted Life Years
Rare Diseases
United States
absenteeism
cardiovascular disease
caregiver burden
cost benefit analysis
cost effectiveness analysis
diabetes mellitus
diseases
drug cost
drug therapy
economics
evaluation study
funding
health care cost
health care quality
health care system
health equity
household
human
leisure
oncology
Loading...